Jennifer R Wang, Mark E Zafereo, Wenyi Wang, Corinne Joshu, Debashree Ray
The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 1, January 2024, Pages e306–e313
https://doi.org/10.1210/clinem/dgad407
Genome-wide association studies have identified germline variants associated with elevated PTC risk. It is also known that somatic driver mutations contribute to PTC development and as such PTCs can be further categorized into different molecular subtypes based on their somatic alterations. However, it remains unknown whether identified germline variants predictive of PTC risk are associated with specific molecular subtypes.
The primary goal of the present study is to determine whether germline genetic risk, as assessed using a polygenic score (PGS), is associated with molecular subtypes of papillary thyroid carcinoma (PTC), defined based on tumor driver mutation status.
This study was carried out using data from The Cancer Genome Atlas (TCGA) thyroid cancer study. A previously validated 10–single-nucleotide variation PGS for PTC derived from genome-wide association study hits was calculated to ascertain germline genetic risk. The primary molecular subtypes of interest were defined by tumor driver mutation status (BRAFV600E-mutated vs RAS-mutated vs “other”). We also explored associations between PGS and molecular subtypes defined by messenger RNA (mRNA) expression, microRNA expression, and DNA methylation patterns. Polytomous logistic regression analysis was used to assess the association between PGS and PTC molecular subtype with and without adjustment for clinical variables. Odds ratios (ORs) with their 95% CIs were estimated.
A total of 359 patients were included in the study. PGS was significantly associated specific tumor molecular subtypes defined by tumor driver mutation status. Increasing germline risk was associated with having a higher odd of BRAFV600E-mutated PTC compared to PTCs without driver mutations in the “other” category. No significant difference was detected in terms of PGS tumor categorization in the RAS subtype compared to BRAFV600E. In exploratory analyses, PGS was also associated with mRNA-, microRNA-, and DNA methylation-defined molecular subtypes, as defined by the TCGA PTC study.
PGS has molecular subtype-specific associations in PTC, which has implications for their use in risk prediction.
We provide our journal authors with a variety of resources for increasing the discoverability and citation of their published work. Use these tools and tips to broaden the impact of your article.
Read our special collections of Endocrine Society journal articles, curated by topic, Altmetric Attention Scores, and Featured Article designations.